PureTech Health (PRTC) Return on Assets (2025)
PureTech Health (PRTC) reported Return on Assets of 0.0% for Q4 2025, down 6.24% on a QoQ basis from 0.0% in Q2 2025.
PureTech Health (PRTC) has 1 years of Return on Assets data on file, last reported at 0.0% in Q4 2025.
- Quarterly Return on Assets changed N/A year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed N/A YoY) and the FY2025 annual result came in at 0.0%, changed N/A from the prior year.
- Return on Assets slipped to 0.0% in Q4 2025 per PRTC's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q2 2025 and bottomed at 0.0% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -0.01% |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 0.00% |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 0.00% |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 0.00% |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |